Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease

Blood Coagul Fibrinolysis. 2023 Oct 1;34(7):462-464. doi: 10.1097/MBC.0000000000001251. Epub 2023 Oct 13.

Author

Craig D Seaman^{1

2}

Affiliations

¹ Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh.
² Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, USA.

No abstract available

Publication types

Letter

MeSH terms

Deamino Arginine Vasopressin / therapeutic use
Factor VIII
Hemostatics* / therapeutic use
Humans
von Willebrand Disease, Type 1*
von Willebrand Diseases* / drug therapy
von Willebrand Factor

Substances

Deamino Arginine Vasopressin
Hemostatics
Factor VIII
von Willebrand Factor